BackIonis Pharmaceuticals Overview

Ionis Pharmaceuticals Receivables

Latest receivables for IONS: $59M.

Get informed when a big investor buys or sells

+ Follow
Receivables
$58.84M

Peer trimmed avg / median

Loading

Ionis Pharmaceuticals Receivables History

Loading

Ionis Pharmaceuticals vs. peers: Receivables Comparison

Loading

Ionis Pharmaceuticals Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Ionis Pharmaceuticals (IONS) FAQ

Ionis Pharmaceuticals (IONS) currently reports a receivables of $59M as of June 2026. In the prior-year period, the figure was $0. Use the charts on this page to explore Ionis Pharmaceuticals's receivables history and peer comparisons.

Ionis Pharmaceuticals's receivables changed from $0 to $59M (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Ionis Pharmaceuticals reported $59M in receivables as of June 2026. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $59M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Ionis Pharmaceuticals, and consider following IONS for alerts when major investors trade the stock.

Ionis Pharmaceuticals is classified in the Healthcare sector. On receivables, it currently shows $59M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IONS with unrelated industries.